ASH 2018 Myeloma News

Patient Power was on-site at the 2018 American Society of Hematology (ASH) meeting in San Diego to bring you the latest myeloma treatment and research news.

Email this program

Get Link

From Holistic Health Guru to Patient Advocate: The Importance of Respecting Evidence-Based Medicine

Myeloma patient and author Cherie Rineker shares how her perspective shifted from holistic care to becoming a myeloma treatment research advocate. Watch to learn why.

Published:

Myeloma News From ASH 2018: Patient Advocate Perspective

As part of our coverage of the 2018 American Society of Hematology (ASH) annual meeting, myeloma survivor and patient advocate Cindy Chmielewski shares her perspective on the latest news in multiple myeloma.

Published:

Myeloma News From ASH 2018: Encouraging Clinical Trial Updates From Dr. Ajai Chari

Patient Power founder Andrew Schorr is joined by leading myeloma expert Dr. Ajai Chari at the 2018 American Society of Hematology (ASH) annual meeting to discuss where there is an unmet need in myeloma care and share exciting clinical trial data with novel agents.

Published:

Myeloma News From ASH 2018: Groundbreaking Data for the Future of Myeloma

What's the recent groundbreaking data for the future of myeloma treatment? Watch as myeloma expert Dr. Fatih Davies shares research breakthroughs from ASH 2018.

Published:

Myeloma Expert Shares Highlights From ASH 2018

Patient Power founder Andrew Schorr is joined by multiple myeloma specialist Dr. James Berenson to discuss exciting research developments announced at the 2018 American Society of Hematology (ASH) annual meeting in an ever-changing treatment paradigm. Tune in to hear the latest news.

Published:

News From ASH 2018: A Multitude of Options in Myeloma

Dr. Robert Orlowski from The University of Texas MD Anderson Cancer Center weighs in on the flurry of myeloma news out of the ASH 2018 meeting.

Published:

Myeloma Patient Perspective: "MRD Testing Gave Me Peace of Mind"

Cherie Rineker, a myeloma patient, author and blogger shares her experience after having MRD testing.

Published:

Myeloma News From ASH 2018: CAR-T Therapy, Antibody Drug Conjugates, Maintenance Strategies

On-site in San Diego, CA, Patient Power founder Esther Schorr is joined by leading myeloma expert Dr. Amrita Krishnan to discuss highlights from the 2018 American Society of Hematology (ASH) annual meeting. Dr. Krishnan explains what exciting research advances were made and the “top three” in treatment development for myeloma patients.

Published:

ASH 2018 Daily Wrap: Myeloma News

In day two of Patient Power’s daily wrap-up from the 2018 American Society of Hematology (ASH) meeting in San Diego, Patient Power founders Andrew and Esther Schorr are joined by a panel of leading experts to discuss impressive treatment advances and important headlines in clinical research. Watch now to find out the latest news in cancer care.

Published:

Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on January 23, 2019